PET/MRI and PET/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study. 2019

Miriam K Rutegård, and Malin Båtsman, and Jan Axelsson, and Patrik Brynolfsson, and Fredrik Brännström, and Jörgen Rutegård, and Ingrid Ljuslinder, and Lennart Blomqvist, and Richard Palmqvist, and Martin Rutegård, and Katrine Riklund
Department of Radiation Sciences, Diagnostic Radiology, Umeå University, SE-901 85, Umeå, Sweden. miriam.rutegard@diagrad.umu.se.

OBJECTIVE The role of hybrid imaging using 18F-fluoro-2-deoxy-D-glucose positron-emission tomography (FDG-PET), computed tomography (CT) and magnetic resonance imaging (MRI) to improve preoperative evaluation of rectal cancer is largely unknown. To investigate this, the RECTOPET (REctal Cancer Trial on PET/MRI/CT) study has been launched with the aim to assess staging and restaging of primary rectal cancer. This report presents the study workflow and the initial experiences of the impact of PET/CT on staging and management of the first patients included in the RECTOPET study. METHODS This prospective cohort study, initiated in September 2016, is actively recruiting patients from Region Västerbotten in Sweden. This pilot study includes patients recruited and followed up until December 2017. All patients had a biopsy-verified rectal adenocarcinoma and underwent a minimum of one preoperative FDG-PET/CT and FDG-PET/MRI examination. These patients were referred to the colorectal cancer multidisciplinary team meeting at Umeå University Hospital. All available data were evaluated when making management recommendations. The clinical course was noted and changes consequent to PET imaging were described; surgical specimens underwent dedicated MRI for anatomical matching between imaging and histopathology. RESULTS Twenty-four patients have so far been included in the study. Four patients were deemed unresectable, while 19 patients underwent or were scheduled for surgery; one patient was enrolled in a watch-and-wait programme after restaging. Consequent to taking part in the study, two patients were upstaged to M1 disease: one patient was diagnosed with a solitary hepatic metastasis detected using PET/CT and underwent metastasectomy prior to rectal cancer surgery, while one patient with a small, but metabolically active, lung nodulus experienced no change of management. PET/MRI did not contribute to any recorded change in patient management. CONCLUSIONS The RECTOPET study investigating the role of PET/CT and PET/MRI for preoperative staging of primary rectal cancer patients will provide novel data that clarify the value of adding hybrid to conventional imaging, and the role of PET/CT versus PET/MRI. BACKGROUND NCT03846882 .

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072078 Positron Emission Tomography Computed Tomography An imaging technique that combines a POSITRON-EMISSION TOMOGRAPHY (PET) scanner and a CT X RAY scanner. This establishes a precise anatomic localization in the same session. CT PET,CT PET Scan,PET CT Scan,PET-CT,PET-CT Scan,Positron Emission Tomography-Computed Tomography,CT PET Scans,CT Scan, PET,CT Scans, PET,PET CT Scans,PET Scan, CT,PET Scans, CT,PET-CT Scans,Scan, CT PET,Scan, PET CT,Scan, PET-CT,Scans, CT PET,Scans, PET CT,Scans, PET-CT
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Miriam K Rutegård, and Malin Båtsman, and Jan Axelsson, and Patrik Brynolfsson, and Fredrik Brännström, and Jörgen Rutegård, and Ingrid Ljuslinder, and Lennart Blomqvist, and Richard Palmqvist, and Martin Rutegård, and Katrine Riklund
June 2008, European radiology,
Miriam K Rutegård, and Malin Båtsman, and Jan Axelsson, and Patrik Brynolfsson, and Fredrik Brännström, and Jörgen Rutegård, and Ingrid Ljuslinder, and Lennart Blomqvist, and Richard Palmqvist, and Martin Rutegård, and Katrine Riklund
August 2010, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Miriam K Rutegård, and Malin Båtsman, and Jan Axelsson, and Patrik Brynolfsson, and Fredrik Brännström, and Jörgen Rutegård, and Ingrid Ljuslinder, and Lennart Blomqvist, and Richard Palmqvist, and Martin Rutegård, and Katrine Riklund
January 2011, Duodecim; laaketieteellinen aikakauskirja,
Miriam K Rutegård, and Malin Båtsman, and Jan Axelsson, and Patrik Brynolfsson, and Fredrik Brännström, and Jörgen Rutegård, and Ingrid Ljuslinder, and Lennart Blomqvist, and Richard Palmqvist, and Martin Rutegård, and Katrine Riklund
August 2007, European radiology,
Miriam K Rutegård, and Malin Båtsman, and Jan Axelsson, and Patrik Brynolfsson, and Fredrik Brännström, and Jörgen Rutegård, and Ingrid Ljuslinder, and Lennart Blomqvist, and Richard Palmqvist, and Martin Rutegård, and Katrine Riklund
January 2004, Radiographics : a review publication of the Radiological Society of North America, Inc,
Miriam K Rutegård, and Malin Båtsman, and Jan Axelsson, and Patrik Brynolfsson, and Fredrik Brännström, and Jörgen Rutegård, and Ingrid Ljuslinder, and Lennart Blomqvist, and Richard Palmqvist, and Martin Rutegård, and Katrine Riklund
September 2022, Cancer imaging : the official publication of the International Cancer Imaging Society,
Miriam K Rutegård, and Malin Båtsman, and Jan Axelsson, and Patrik Brynolfsson, and Fredrik Brännström, and Jörgen Rutegård, and Ingrid Ljuslinder, and Lennart Blomqvist, and Richard Palmqvist, and Martin Rutegård, and Katrine Riklund
November 2019, Abdominal radiology (New York),
Miriam K Rutegård, and Malin Båtsman, and Jan Axelsson, and Patrik Brynolfsson, and Fredrik Brännström, and Jörgen Rutegård, and Ingrid Ljuslinder, and Lennart Blomqvist, and Richard Palmqvist, and Martin Rutegård, and Katrine Riklund
January 2018, Cancer imaging : the official publication of the International Cancer Imaging Society,
Miriam K Rutegård, and Malin Båtsman, and Jan Axelsson, and Patrik Brynolfsson, and Fredrik Brännström, and Jörgen Rutegård, and Ingrid Ljuslinder, and Lennart Blomqvist, and Richard Palmqvist, and Martin Rutegård, and Katrine Riklund
July 2011, Journal of gastroenterology and hepatology,
Miriam K Rutegård, and Malin Båtsman, and Jan Axelsson, and Patrik Brynolfsson, and Fredrik Brännström, and Jörgen Rutegård, and Ingrid Ljuslinder, and Lennart Blomqvist, and Richard Palmqvist, and Martin Rutegård, and Katrine Riklund
August 2016, Clinical nuclear medicine,
Copied contents to your clipboard!